"What is the Prognosis of Polymyalgia Rheumatica?"

Prognosis and Considerations for Polymyalgia Rheumatica

The prognosis of polymyalgia rheumatica (PMR) is influenced by factors such as the severity of the disease and the timeliness of treatment. If patients actively undergo standardized treatment at the early stages of onset and do not experience severe complications, the prognosis is generally favorable. However, if patients do not receive effective treatment, leading to further aggravation of the disease, it may impact their lifespan. It is recommended that patients actively cooperate with doctors for targeted treatments to control disease progression.

I. Prognosis Scenarios

1. Favorable Prognosis: PMR is an autoimmune disease commonly affecting middle-aged and elderly individuals, typically causing muscle pain and stiffness. If patients present with mild symptoms and can cooperate with doctors to take glucocorticoid medications like prednisone acetate tablets after onset, combined with anti-inflammatory and analgesic drugs for improvement, such as celecoxib capsules and diclofenac sodium sustained-release tablets, the prognosis is relatively good.

2. Poor Prognosis: If patients fail to regulate their diet or follow medication instructions during illness, their condition may gradually worsen, potentially leading to bone and joint destruction. As the disease progresses, it may induce complications like lung infections or femoral head necrosis, affecting daily life, work, and even lifespan in severe cases.

II. Precautions

Given the potential for recurrence of PMR, it is essential to develop healthy habits in daily life, avoiding overexertion and cold exposure to reduce the risk of disease onset. Regular follow-up visits to the hospital are also necessary to monitor the disease's recovery progress.